To determine whether fisetin abrogates melanoma cell invasion by inhibiting MEK1/2 and NFκB, we compared the effect of inhibitor of MEK1/2 (PD98059) and NFκB (CAPE) with fistein. Here, MAP2K1 is linked to melanoma.